Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,886 INR | +0.22% | +6.00% | -2.01% |
May. 24 | Gland Pharma Gets Zero Observations from US FDA for API Facility in Andhra Pradesh, India | MT |
May. 23 | Jefferies Adjusts Gland Pharma's Price Target to INR2,240 From INR2,400, Keeps at Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.01% | 3.74B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- GLAND Stock
- News Gland Pharma Limited
- Gland Pharma Gets US FDA's Approval for Generic Stem Cell Mobilizer Injection